Source: Wall Street Journal Online July 20, 2007 - U.S. doctors implanted fewer coronary stents in June than any other ...
June 1, 2007 — Abbott announced it has completed its application to the U.S. Food and Drug Administration (FDA) to seek ...
May 29, 2007 — Abbott announced Friday, May 25, that it has initiated a voluntary, nationwide recall of its ARCHITECT ...
May 29, 2007 — Abbott announced positive results last week from ABSORB, the world’s first clinical trial evaluating the ...
April 9, 2007 — The FDA has approved Abbott's new coated Niaspan (niacin extended-release tablets) for boosting HDL ...
Feb. 7, 2007 — Abbott has announced its plan to launch the world's first drug-eluting stent clinical trial solely in ...
Jan. 29, 2007 — Abbott Vascular surpassed Cordis for the first time in December 2006 as the market leader in peripheral ...
Jan. 5, 2007 — A French court has ruled that Abbott Laboratories’ Xience V drug-eluting coronary stents infringe patents ...
The Emboshield PRO Embolic Protection System received CE approval and will be launched in Europe. Embolic protection ...
A subset analysis of diabetic patients in the SPIRIT II Clinical trial of the XIENCE V Everolimus Eluting Stent System ...